Intan Baru Prana Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Intan Baru Prana Tbk. trades at Rp63 (market cap 103.18B, 799.4K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp236 (market cap 428.75B, 13.83M 24h volume). The key difference: Prodia Diagnostic Line Tbk is far larger — about 4.2× Intan Baru Prana Tbk.'s market cap, and Prodia Diagnostic Line Tbk is more actively traded (13.83M versus 799.4K). Which is the better fit depends on your goals.
| IBFN | PRDL | |
|---|---|---|
Market Cap | 103.18B | 428.75B |
Volume | 799.4K | 13.83M |
Lot | 7.99K | 138.27K |
Turnover | — | 3.27B |
Average Price | — | 236.62 |
Value | — | 3.27B |
Indicative Equilibrium Price | — | 236 |
Indicative Equilibrium Volume | — | 1.74K |
Trailing returns across standard periods
Latest headlines on both assets
PT Intan Baruprana Finance Tbk (the Company) was established based on Notarial Deed No. 19 dated September 4, 1991 and amended by Notarial Deed No. 121 dated June 16, 1993 of Esther Daniar Iskandar, S.H., notary in Jakarta. The Company started its commercial operations in 1997. The Company is part of the Intraco Penta group of companies.
Read more on IBFN →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →